Skip to content
Clinical Trials – home
ItalyBack to Italy

Clinical trials in L'aquila – page 3

33 clinical trials in L'aquila, Italy. Every trial is listed in the EU Clinical Trials Register and updated daily.

ItalyOur site in ItalyStudi-Clinici.it(opens in a new tab)
L'aquila at a glance
33
clinical trials
  • Not yet recruiting0
  • Research sites0
Type of trial
Recruitment status
Quick filters

33 trials in L'aquila

Open in trial search

Migraine+1

Not recruiting

Study of Eptinezumab as Add-on Treatment for Prevention of Migraine in Adults with Both Migraine and Medication Overuse Headache

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Eptinezumab
  • Sponsor:H. Lundbeck A/S

Psoriasis

Not recruiting

Study on Adjustable Brodalumab Dosage for Patients with Moderate-to-Severe Plaque Psoriasis Weighing 120 kg or More

Registered drug
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Brodalumab
  • Sponsor:Leo Pharma A/S

Dermatitis atopic

Not recruiting

Study on the Effectiveness and Safety of Amlitelimab for Patients Aged 12 and Older with Moderate-to-Severe Atopic Dermatitis Using Topical Corticosteroids

Registered drug
Countries:ItalyItaly
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Amlitelimab
  • Sponsor:Sanofi-Aventis Recherche & Developpement
Countries:ItalyItaly
  • Participants:18–64 years
  • Substances:Secukinumab
  • Sponsor:Novartis Pharma AG

Dermatitis atopic

Not recruiting

Study of Upadacitinib and Topical Corticosteroids for Adolescents and Adults with Moderate to Severe Eczema

Registered drug
Countries:ItalyItaly
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Hydrocortisone
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Hidradenitis

Not recruiting

Study on Upadacitinib for Adults and Adolescents with Moderate to Severe Hidradenitis Suppurativa After Anti-TNF Therapy Failure

Investigational
Countries:ItalyItaly
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Upadacitinib
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Dermatitis atopic

Not recruiting

Study of Upadacitinib for Adolescents and Adults with Moderate to Severe Eczema

Investigational
Countries:ItalyItaly
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Upadacitinib
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Migraine+2

Not recruiting

Study on Long-Term Safety of Atogepant for Preventing Migraine in Patients with Chronic or Episodic Migraine

InvestigationalNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Atogepant
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Neurodermatitis

Not recruiting

Study of Rocatinlimab in Adults with Prurigo Nodularis Not Adequately Controlled by Topical Treatments

Investigational
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Rocatinlimab
  • Sponsor:Amgen Inc.

Other cities in Italy

The busiest research cities in the country

All 237 cities in Italy

Clinical research in L'aquila

What the registry says about research in the country

01 Dermatological Studies

Current clinical trials focus on innovative treatments for atopic dermatitis and prurigo nodularis, evaluating new therapeutic approaches for managing severe skin conditions.

  • Moderate to severe atopic dermatitis treatment
  • Prurigo nodularis management
  • Alopecia areata interventions

Research emphasizes long-term efficacy and safety of treatments like upadacitinib and amlitelimab.

02 Neurological Research

Studies concentrate on migraine prevention and treatment, including medication overuse headache and innovative approaches using eptinezumab and atogepant.

  • Chronic and episodic migraine management
  • Stroke prevention and treatment
  • Intracerebral hemorrhage interventions

Trials explore both acute treatment options and preventive therapies for neurological conditions.

03 Autoimmune Conditions

Research focuses on treating Sjögren's Syndrome and related autoimmune disorders, evaluating novel therapeutic approaches for systemic manifestations.

  • Systemic disease management
  • Long-term treatment efficacy
  • Symptom control strategies

Studies aim to improve quality of life for patients with chronic autoimmune conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.